March 2018- Volume 14, Issue 3

In this Issue

Commentary

Out of order: Seeing things

Out of order: Seeing things

Many discoveries and new fields come and go (when it comes to noteworthiness and newsworthiness) in the life sciences, but perhaps the microbiome will be something of a different nature, both in terms of notoriety, complexity and impact for many years to come

Research & Development

Have a (mouse) heart!

Have a (mouse) heart!

Single-cell characterization of non-myocyte heart cells offers new insights into structure and function

Are immortalized stem cells poor surrogates?

Are immortalized stem cells poor surrogates?

Deleted gene that immortalizes MSCs may be critical to their function

Corning introduces new dissolvable microcarriers

Corning introduces new dissolvable microcarriers

Product offering is designed for improved large-scale cell expansion

Pieris and Seattle Genetics announce immuno-oncology collaboration

Pieris and Seattle Genetics announce immuno-oncology collaboration

Companies to evaluate novel bispecific agents combining anticalin technology with select antibodies

Protein power

Protein power

New methods emerge to manufacture therapeutic proteins

‘Virus-cracking’ molecules

‘Virus-cracking’ molecules

Indiana University team fights hepatitis B

Clinical Trials

A digital path for studies

A digital path for studies

TriNetX tech helps Sanofi streamline clinical trial protocols, improve efficiency and extend digital strategy

Replacing a needle with a pill

Replacing a needle with a pill

Allergan achieves positive top-line Phase 3 results for oral CGRP receptor antagonist targeting acute treatment of migraine

Out of the starting gate

Out of the starting gate

A roundup of clinical trial startups and initial breakthroughs

Viral suppression

Viral suppression

Study investigates two new drugs for HIV

Business & Government Policy

Supporting science startups

Supporting science startups

Elsevier welcomes six biotech and pharma companies to The Hive

On the cutting edge

On the cutting edge

A roundup of instrumentation, software and other tools and technology news

NHGRI: Seeing 2020

NHGRI: Seeing 2020

Strategic plan aims to engage experts and diverse communities to identify paradigm-shifting areas of genomics

Diagnostics

A novel companion biomarker for glaucoma

A novel companion biomarker for glaucoma

Q BioMed signs exclusive option with Washington University related to growth differentiation factor-15

A new ‘path’ for Parsortix

A new ‘path’ for Parsortix

ANGLE and Abbott seek blood test for metastatic breast cancer

Money for MeMed

Money for MeMed

$4M grant awarded to support transfer to manufacturing of MeMed’s pioneering point-of-care platform

microRNAs for earlier diagnosis?

microRNAs for earlier diagnosis?

Dana-Farber/Brigham and Women’s team identifies set of seven microRNAs that could detect early-stage ovarian cancer

FDA approval for Hologic’s Aptima

FDA approval for Hologic’s Aptima

Assay for quantitation of hepatitis B viral load receives pre-market approval

Discovery

Working the crowd

Working the crowd

Open-access communities launch to support drug discovery efforts

Compugen catches a new checkpoint

Compugen catches a new checkpoint

Discovery of ILDR2 as a novel immune checkpoint and potential for autoimmune diseases published in back-to-back papers

Getting the ‘Akt’ straight in angiogenesis

Getting the ‘Akt’ straight in angiogenesis

Sanford Burnham team details how the R-Ras/Akt pathway triggers and supports new blood vessel growth

Pushing paper

Pushing paper

A roundup of discovery-related research published recently in journals

An ‘intelligent’ approach

An ‘intelligent’ approach

AI and machine-learning approaches seem to be an industry theme for Q1 2018

Preclinical

Tag team against Usher syndrome

Tag team against Usher syndrome

Foundation Fighting Blindness and ProQR enter into a partnership to develop QR-421a for genetic disease

‘Not just science, but an art form’

‘Not just science, but an art form’

Kinase inhibitor may prove useful in treating rare genetic disease

In with the new

In with the new

RWTH explores biohybrid development and digital notebook option

Double the good news

Double the good news

BioLineRx’s BL-8040 and AGI-134 programs boost survival in preclinical studies

China- and U.S.-bound for RX-0201

China- and U.S.-bound for RX-0201

Rexahn announces collaboration with Zhejiang Haichang Biotechnology for development of Archexin to treat hepatocellular carcinoma

A deal for artificial lymph node technology

A deal for artificial lymph node technology

ProBioGen and TEVA enter into research license deal on tech to assess drug effects on the immune system

Feature

Spotlight on Oncology

Spotlight on Oncology

New discoveries in cancer-related targets and pathways, plus other recent news in oncology R&D and clinical trials

Special Focus on Neuroscience and Neurology

Special Focus on Neuroscience and Neurology

Looking at recent cutting-edge research in potential therapeutics for neurological conditions, plus additional news on autism breakthroughs, addiction treatment and more

Editor's Focus

Editor’s focus: So much to share

Editor’s focus: So much to share

A tour of what we have to offer you in our largest-ever issue of the magazine, from neurology to oncology and plenty of other places in the pharma and biotech world

Contract Services

Coming together in contract services

Coming together in contract services

A roundup of mergers and alliance deals in the contract services and pharma consulting spaces

Innovate UK confident in Cobra

Innovate UK confident in Cobra

Cobra Biologics receives two separate grants from British innovation funder

Presenting a plan for growth

Presenting a plan for growth

Vetter introduces South Korea’s pharma and biotech community to company management

Kicking up clinical capture

Kicking up clinical capture

IACT Health selects Alpha Clinical Systems ACS360 e-source platform for trial data capture
Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

March 2024 Issue Front Cover

Latest Issue  

• Volume 20 • Issue 2 • March 2024

March 2024

March 2024 Issue